Clinical Trial

Heart Failure Efficacy and Research Trial (HEART) Platform

Study acronym: HEART
Not Yet Recruiting
View on ClinicalTrials.gov →
Summary
The Heart Failure Efficacy and Research Trial (HEART) Platform is a multicenter, randomized platform study designed to improve outcomes for patients with heart failure through the simultaneous and sequential evaluation of multiple interventions across the spectrum of heart failure.
Protocol Amendment History 4 amendments
This ClinicalTrials.gov record has been amended 4 times since 2026-02-19; most recent amendment 2026-06-26.
Trial Details
NCT Number NCT07428135
Lead Sponsor University of Alberta
Collaborators: Canadian VIGOUR Centre
Conditions Heart Failure
Enrollment 1,000 participants
Start Date 2026-07
Primary Completion 2036-03 (estimated)
Study Completion 2037-03 (estimated)
Updated on ClinicalTrials.gov 2026-06-30